BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2711413)

  • 1. Mode of metabolism is altered in 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-treated rats.
    Muzi G; Gorski JR; Rozman K
    Toxicol Lett; 1989 Apr; 47(1):77-86. PubMed ID: 2711413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Composition of diet modifies toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in cold-adapted rats.
    Muzi G; Gorski JR; Rozman K
    Arch Toxicol; 1987; 61(1):34-9. PubMed ID: 3439872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in thyroid hormones and thyroxine glucuronidation in hamsters compared with rats following treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Henry EC; Gasiewicz TA
    Toxicol Appl Pharmacol; 1987 Jun; 89(2):165-74. PubMed ID: 3111013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid hormones modulate the toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).
    Rozman K; Rozman T; Scheufler E; Pazdernik T; Greim H
    J Toxicol Environ Health; 1985; 16(3-4):481-91. PubMed ID: 4087313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intermediary metabolism of the mature rat following 2,3,7,8-tetrachlorodibenzo-p-dioxin treatment.
    Christian BJ; Menahan LA; Peterson RE
    Toxicol Appl Pharmacol; 1986 Apr; 83(2):360-78. PubMed ID: 3961820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circadian alterations in prolactin, corticosterone, and thyroid hormone levels and down-regulation of prolactin receptor activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Jones MK; Weisenburger WP; Sipes IG; Russell DH
    Toxicol Appl Pharmacol; 1987 Feb; 87(2):337-50. PubMed ID: 3824389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of the wasting syndrome to lethality in rats treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Christian BJ; Inhorn SL; Peterson RE
    Toxicol Appl Pharmacol; 1986 Feb; 82(2):239-55. PubMed ID: 3945951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated plasma corticosterone levels and histopathology of the adrenals and thymuses in 2,3,7,8-tetrachlorodibenzo-p-dioxin-treated rats.
    Gorski JR; Muzi G; Weber LW; Pereira DW; Iatropoulos MJ; Rozman K
    Toxicology; 1988 Dec; 53(1):19-32. PubMed ID: 3201474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Body weight regulation in rats treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Seefeld MD; Keesey RE; Peterson RE
    Toxicol Appl Pharmacol; 1984 Dec; 76(3):526-36. PubMed ID: 6506077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NTP technical report on the toxicology and carcinogenesis studies of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (CAS No. 1746-01-6) in female Harlan Sprague-Dawley rats (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Apr; (521):4-232. PubMed ID: 16835633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue-specific alterations of de novo fatty acid synthesis in 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-treated rats.
    Gorski JR; Weber LW; Rozman K
    Arch Toxicol; 1988; 62(2-3):146-51. PubMed ID: 3196149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of alterations in energy metabolism to hypophagia in rats treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Potter CL; Menahan LA; Peterson RE
    Fundam Appl Toxicol; 1986 Jan; 6(1):89-97. PubMed ID: 3086171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Some endocrine and morphological aspects of the acute toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).
    Gorski JR; Muzi G; Weber LW; Pereira DW; Arceo RJ; Iatropoulos MJ; Rozman K
    Toxicol Pathol; 1988; 16(3):313-20. PubMed ID: 3057589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypophagia-induced weight loss in mice, rats, and guinea pigs treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Kelling CK; Christian BJ; Inhorn SL; Peterson RE
    Fundam Appl Toxicol; 1985 Aug; 5(4):700-12. PubMed ID: 4043592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypothyroxinemia and hypothermia in rats in response to 2,3,7,8-tetrachlorodibenzo-p-dioxin administration.
    Potter CL; Sipes IG; Russell DH
    Toxicol Appl Pharmacol; 1983 Jun; 69(1):89-95. PubMed ID: 6134353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced activities of key enzymes of gluconeogenesis as possible cause of acute toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in rats.
    Weber LW; Lebofsky M; Stahl BU; Gorski JR; Muzi G; Rozman K
    Toxicology; 1991 Feb; 66(2):133-44. PubMed ID: 1849669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid status and thermogenesis in rats treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Potter CL; Moore RW; Inhorn SL; Hagen TC; Peterson RE
    Toxicol Appl Pharmacol; 1986 Jun; 84(1):45-55. PubMed ID: 3715868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced gluconeogenesis in 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-treated rats.
    Gorski JR; Weber LW; Rozman K
    Arch Toxicol; 1990; 64(1):66-71. PubMed ID: 2306197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of thyroidectomy and thyroxine on 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) induced toxicity.
    Rozman K; Rozman T; Greim H
    Toxicol Appl Pharmacol; 1984 Feb; 72(2):372-6. PubMed ID: 6695381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Digestible energy and efficiency of feed utilization in rats treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Seefeld MD; Peterson RE
    Toxicol Appl Pharmacol; 1984 Jun; 74(2):214-22. PubMed ID: 6740672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.